DESMOPRESSINE TEVA 120 micrograms, sublingual tablet 100 tablets
Active ingredients: Desmopressin acetate, Desmopressin
Commercialized according to BDPMDispensing in France: Prescription only
Tablet100 tabletssublinguale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- DESMOPRESSINE TEVA 120 microgrammes, comprimé sublingual
- Pharmaceutical form
- comprimé
- Route of administration
- sublinguale
- Presentation description
- plaquette(s) OPA : polyamide orienté aluminium PVC polyéthylène de 100 comprimé(s)
- Marketing authorisation holder
- TEVA (PAYS-BAS)
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 3 Jun 2024
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68239932CIP73028145CIP133400930281451Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| DESMOPRESSINEcomprimé | 120 microgrammes · un comprimé | FT |
| ACÉTATE DE DESMOPRESSINEcomprimé | — | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.